3Liu C, McNeil JE, Greenwood R. Rehabilitation outcomes after brain injury: disability measures or goal achievement? [J]. Clin Rehabil, 2004, 18(4): 398-404.
4Guercio J, Davis P, Faw G, et al. Increasing functional rehabilitation in acquired brain injury treatment: effective applications of behavioural principles [J]. Brain Inj, 2002, 16(10): 849-860.
5Noda R, Maeda Y, Yoshino A, et al. Therapeutic time window for musicokinetic therapy in a persistent vegetative state after severe brain damage [J]. Brain Inj, 2004, 18(5): 509-515.
6Mandleberg IA, Brooks DN. Cognitive recovery after severe head injury,serial testing on the wechsler adult intelligences scale [J] . J Neurol Neurosurg Psychiatry, 1975, 38(11): 1121-1126.
7Brooks DN. Memory and head injury [J]. J Nerv Ment Dis, 1972, 155(5): 350-355.
8Wang Z, Song D, Berger TW, et al. Contribution of NMDA receptor channels to the expression of LTP in the hippocampal dentate gyrus [J]. Hippocampus, 2002, 12(5): 680-688.
9Borroni AM, Fichtenholtz H, Woodside BL, et al. Role of voltage-dependent calcium channel long-term potentiation (LTP) and NMDA LTP in spatial memory [J]. J Neurosci, 2000, 20(24): 9272-9276.
二级参考文献8
1Banfi S, Dorigotti L. Experimental behavior studies with oxiracetam on different types of chronic cerebral impairment [J]. Clin Neuropharmacol, 1986, 3 (Suppl): S19-26.
2Saletu B, Linzmayer L, Grunberger J, et al. Double-blind, placebo-controlled, clinical, psychometric and neurophysiological investigations with oxiracetam in the organic brain syndrome of late life [J]. Neuropsychobiology, 1985, 13(1-2): 44-52.
3Maina G, Fiori L, Torta R, et al. Oxiracetam in the treatment of primary degenerative and multi-infarct dementia: a double-blind, placebo-controlled study [J]. Neuropsychobiology, 1989, 21(1): 141-145.
4Bottini G, Vallar G, Cappa S, et al. Oxiracetam in dementia: a double-blind, placebo-controlled study [J]. Acta Neurol Scand, 1992, 86(3): 237-241.
5Parnetti L, Mecocci P, Petrini A, et al. Neuropsychological results of long-term therapy with oxiracetam in patients with dementia of Alzheimei type and multi-infarct dementia in comparison with a control group [J]. Neuropsychobiology, 1989, 22(2): 97-100.
